US RESEARCH ROUNDUP-Abbvie, TransDigm Group, Visa

By Reuters News

- Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, TransDigm Group and Visa on Wednesday.


HIGHLIGHTS


* Abbvie ABBV.N: Berenberg raises target price to $305 from $275

* Constellation Energy Corp CEG.O: Raymond James raises target price to $347 from $341

* Primerica, Inc. PRI.N: KBW raises target price to $332 from $330

* TransDigm Group Incorporated TDG.N: TD Cowen raises target price to $1350 from $1300

* Visa Inc. V.N: Bernstein raises target price to $486 from $475

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Abbvie ABBV.N: Berenberg raises target price to $305 from $275

* Aflac Incorporated AFL.N: KBW raises target price to $123 from $120

* Alamo Group Inc. ALG.N: D.A. Davidson cuts target price to $161 from $188

* Ambiq Micro, Inc. AMBQ.N: Jefferies cuts target price to $70 from $90

* Ambiq Micro, Inc. AMBQ.N: Needham cuts target price to $65 from $85

* Block, Inc. XYZ.N: Bernstein raises target price to $110 from $95

* Bridgebio Oncology Therapeutics BBOT.O: Piper Sandler cuts target price to $15 from $21

* Constellation Energy Corp CEG.O: Raymond James raises target price to $347 from $341

* Corebridge Financial Inc CRBG.N: KBW raises target price to $44 from $43

* Coreweave, Inc. CRWV.O: Baird cuts target price to $100 from $130

* Cryoport, Inc. CYRX.O: Guggenheim raises target price to $24 from $19

* D-Wave Quantum Inc. QBTS.O: Needham cuts target price to $20 from $40

* Etoro Group Ltd. : KBW cuts target price to $22 from $27.5

* FIS FIS.N: Bernstein cuts target price to $31 from $48

* Fiserv Inc FISV.O: Bernstein raises target price to $70 from $60

* Flutter Entertainment Plc FLUT.N: Berenberg cuts target price to $105 from $130

* Genedx Holdings Corp. WGS.O: Piper Sandler cuts target price to $65 from $95

* Global Payments Inc GPN.N: Bernstein raises target price to $100 from $86

* Gossamer Bio, Inc. GOSS.O: Piper Sandler cuts target price to $96 from $120

* Ionis Pharmaceuticals, Inc. IONS.O: Piper Sandler cuts target price to $60 from $87

* KKR KKR.N: Piper Sandler raises target price to $125 from $121

* Leonardo Drs Inc DRS.O: JP Morgan cuts target price to $48 from $53

* Liquidia Corporation LQDA.O: Needham raises target price to $66 from $58

* Mastercard MA.N: Bernstein raises target price to $764 from $730

* Metlife, Inc. MET.N: KBW raises target price to $111 from $108

* NRG Energy Inc NRG.N: CIBC cuts target price to $154 from $159

* Palisade Bio Inc PALI.O: Piper Sandler cuts target price to $16 from $25

* PayPal PYPL.O: Bernstein raises target price to $60 from $55

* Pepgen Inc. PEPG.O: Leerink Partners raises target price to $16 from $10

* Primerica, Inc. PRI.N: KBW raises target price to $332 from $330

* Propetro Holding Corp. PUMP.N: zephirin Group raises to buy from hold

* Propetro Holding Corp. PUMP.N: zephirin Group cuts price objective by $1 to $11

* Prudential Financial Inc PRU.N: KBW raises target price to $125 from $119

* Republic Services Inc RSG.N: JP Morgan raises to overweight from neutral

* Republic Services Inc RSG.N: JP Morgan raises target price to $295 from $265

* Stubhub Holdings, Inc STUB.N: JP Morgan cuts target price to $8 from $11

* Take-Two Interactive Software, Inc. TTWO.O: HSBC cuts target price to $282 from $285

* Toast, Inc. TOST.N: Bernstein cuts to market perform from outperform

* Toast, Inc. TOST.N: Bernstein cuts target price to $38 from $45

* TransDigm Group Incorporated TDG.N: RBC raises target price to $1300 from $1200

* TransDigm Group Incorporated TDG.N: TD Cowen raises target price to $1350 from $1300

* Universal Health Services, Inc. UHS.N: RBC raises target price to $207 from $183

* Upstream Bio Inc UPB.O: Piper Sandler cuts target price to $40 from $75

* Visa Inc. V.N: Bernstein raises target price to $486 from $475

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.